DE68926746D1 - Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel - Google Patents
Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittelInfo
- Publication number
- DE68926746D1 DE68926746D1 DE68926746T DE68926746T DE68926746D1 DE 68926746 D1 DE68926746 D1 DE 68926746D1 DE 68926746 T DE68926746 T DE 68926746T DE 68926746 T DE68926746 T DE 68926746T DE 68926746 D1 DE68926746 D1 DE 68926746D1
- Authority
- DE
- Germany
- Prior art keywords
- flammable
- immunity
- medicinal products
- based medicinal
- suppressing medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
- C07H11/04—Phosphates; Phosphites; Polyphosphates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPI994288 | 1988-08-19 | ||
PCT/AU1989/000350 WO1990001938A1 (en) | 1988-08-19 | 1989-08-18 | Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68926746D1 true DE68926746D1 (de) | 1996-08-01 |
DE68926746T2 DE68926746T2 (de) | 1996-11-28 |
Family
ID=3773299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68926746T Expired - Lifetime DE68926746T2 (de) | 1988-08-19 | 1989-08-18 | Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0429522B1 (de) |
AT (1) | ATE139699T1 (de) |
DE (1) | DE68926746T2 (de) |
WO (1) | WO1990001938A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5308838A (en) * | 1982-05-07 | 1994-05-03 | Carrington Laboratories, Inc. | Uses of aloe products |
US5646123A (en) * | 1991-06-10 | 1997-07-08 | Alberta Research Council | Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen |
GB2299025B (en) * | 1992-03-17 | 1996-11-27 | British Tech Group | Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye |
GB9205800D0 (en) * | 1992-03-17 | 1992-04-29 | British Tech Group | Treatment of fibrotic disorders |
US5747461A (en) * | 1994-07-26 | 1998-05-05 | Markov; Angel K. | Synergistic administration of cyclosporine and fructose diphosphate |
SE9403137D0 (sv) * | 1994-09-20 | 1994-09-20 | Perstorp Ab | Derivatives of carbohydrates and compositions containing them |
GB9516012D0 (en) * | 1995-08-04 | 1995-10-04 | Univ Manchester | Pharmaceutical composition |
US6566339B1 (en) | 1995-08-04 | 2003-05-20 | Renovo Limited | Pharmaceutical composition |
US6093388A (en) * | 1996-08-12 | 2000-07-25 | Btg International Limited | Mannose-6-phosphate composition and its use in treating fibrotic disorders |
AUPO309896A0 (en) | 1996-10-18 | 1996-11-14 | Australian National University, The | Novel phosphosugars and phosphosugar-containing compounds having anti-inflammatory activity |
US20050186645A1 (en) | 2003-12-18 | 2005-08-25 | Yehudit Amor | Method for analyzing a glycomolecule |
US7276486B2 (en) | 2004-03-15 | 2007-10-02 | Kimberly-Clark Worldwide, Inc. | Compositions for vaginal treatment |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE334250C (de) * | 1918-05-11 | 1921-03-14 | Farbenfab Vorm Bayer F & Co | Verfahren zur Darstellung von Fruktosemonophosphorsaeure |
US4122179A (en) * | 1976-06-03 | 1978-10-24 | Enrico Corvi Mora | Acid addition salts of vincamine and apovincamine |
IT1143956B (it) * | 1980-03-12 | 1986-10-29 | Foscama Biomed Chim Farma | Preparato di fruttosio-1,6-difosfato ad azione protettiva della membrana degli eritrociti in pazienti sottoposti a circolazione extracorporea |
JPS58121216A (ja) * | 1982-01-13 | 1983-07-19 | Grelan Pharmaceut Co Ltd | リン含有マンナン |
IT1164363B (it) * | 1983-08-03 | 1987-04-08 | Foscama Biomed Chim Farma | Procedimento terapeutico facente uso di liposomi imcorporati fruttosio 1,6 difosfato e procedimento per la preparazione degli stessi |
IT1209519B (it) * | 1984-04-10 | 1989-08-30 | Poli Ind Chimica Spa | Composti ad attivita'cardiotrofica. |
ES8602951A1 (es) * | 1985-03-15 | 1985-12-16 | Vinas Lab | Procedimiento para la preparacion de un nuevo derivado de lafructosa |
US4703040A (en) * | 1985-04-03 | 1987-10-27 | Markov Angel K | Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP) |
NL8601551A (nl) * | 1985-06-28 | 1987-01-16 | Sandoz Ag | Nieuwe saccharides, hun bereiding en farmaceutische samenstellingen, die hen bevatten. |
US4739046A (en) * | 1985-08-19 | 1988-04-19 | Luzio Nicholas R Di | Soluble phosphorylated glucan |
DE3731953A1 (de) * | 1987-09-23 | 1989-04-06 | Sandoz Ag | Neue saccharide, verfahren zu ihrer herstellung und ihre verwendung |
IT1204764B (it) * | 1986-01-17 | 1989-03-10 | Foscama Biomed Chim Farma | Utilizzazione terapeutica del fruttosio-1,6-difosfato per la protezione nei confronti della tossicita' indotta da somministrazione di antitumorali antraciclinici |
JPH06702B2 (ja) * | 1986-11-05 | 1994-01-05 | 花王株式会社 | 抗アレルギ−剤 |
-
1989
- 1989-08-18 AT AT89909685T patent/ATE139699T1/de not_active IP Right Cessation
- 1989-08-18 DE DE68926746T patent/DE68926746T2/de not_active Expired - Lifetime
- 1989-08-18 EP EP89909685A patent/EP0429522B1/de not_active Expired - Lifetime
- 1989-08-18 WO PCT/AU1989/000350 patent/WO1990001938A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE68926746T2 (de) | 1996-11-28 |
WO1990001938A1 (en) | 1990-03-08 |
EP0429522A1 (de) | 1991-06-05 |
ATE139699T1 (de) | 1996-07-15 |
EP0429522B1 (de) | 1996-06-26 |
EP0429522A4 (en) | 1991-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE158182T1 (de) | Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen | |
DE3382641D1 (de) | Arzneimittel fuer die therapeutische behandlung von alopezie. | |
IS3644A7 (is) | Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur | |
FI932354A0 (fi) | Medicinskt foerfarande foer maetning av blodcirkulationen i ett organ ochmedel haerfoer | |
NO306377B1 (no) | Doseform for avgivelse av et medikament | |
DE68926746D1 (de) | Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel | |
RU92016463A (ru) | Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе | |
SE7902742L (sv) | Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav | |
DE69200711T2 (de) | Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung. | |
DK561089D0 (da) | Anvendelse af lactamimider til fremstilling af laegemidler | |
DE59107336D1 (de) | Oligosaccharidderivate und deren Verwendung in Heilmitteln | |
ES2145902T3 (es) | Aplicacion del riluzole en el tratamiento de las enfermedades mitocondriales. | |
DK0559145T3 (da) | Lægemiddel til truende abort | |
SE9000207D0 (sv) | Laekemedel samt anvaendningen av detsamma | |
KR900009029A (ko) | 가축병 치료용 약물을 투여하는 장치 | |
EP0456842A4 (en) | Medicinal application of m-csf | |
SE8105500L (sv) | Psykotropa lekemedel | |
AU2366388A (en) | A method for the preparation of a pharmaceutical curative for the veterinary and humane medicine, with antiviral and antitumoral effect | |
IT8848016A0 (it) | Dispositivo elettro-medicale eprocedimento per la cura del dolore da nevralgie, malattie reumatiche, chirurgiche ed altre affezioni | |
FR2583755B1 (fr) | Derives de 10 a-methoxy-6-methyl-ergoline, leur preparation et leur application en tant que medicament | |
UA30143A (uk) | Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань | |
NO881870D0 (no) | Doseringsenhet for hudoverfoeringsabsorbsjon av narkotiske analgesiske og antagonistiske stoffer og fremgangsmaate for administrering av samme. | |
IT7828549A0 (it) | Composizione terapeutica per il trattamento di infezioni e malattie di animali da allevamento. | |
ATE178800T1 (de) | Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung | |
BG51774A1 (en) | Pharmaceutical formulation basedon 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-/n-2-pyridylcarboxamide/ -1,1-dioxide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |